52
Participants
Start Date
April 30, 2004
Primary Completion Date
July 31, 2010
Study Completion Date
November 30, 2010
Remune and ALVAC
"* Group 1) Remune™ (1ml i.m.) at weeks 0, 12 and 20 and ALVAC (1 ml i.m.) at weeks 8, 12, 16 and 20);~* Group 2) Remune™ placebo (1ml i.m.) at weeks 0, 12 and 20 and ALVAC (1 ml i.m.) at weeks 8, 12, 16 and 20; or~* Group 3) Remune™ placebo (1ml i.m.) at weeks 0, 12 and 20 and ALVAC placebo (1 ml i.m.) at weeks 8, 12, 16 and 20."
The Ottawa Hospital, General Campus, Ottawa
CHUM Hotel-Dieu, Montreal
Montreal Chest Institute, Montreal
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Ontario HIV Treatment Network
NETWORK
CIHR Canadian HIV Trials Network
NETWORK
Ottawa Hospital Research Institute
OTHER